Ryan Marshall
Corporate Officer/Principal bij IMV INC.
Oorsprong van het eerstegraads netwerk van Ryan Marshall
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
35
| Public Company | Biotechnology | 35 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ryan Marshall via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
DRI Capital, Inc.
 DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Investment Managers | Corporate Officer/Principal | |
| BORALEX INC. | Electric Utilities | Investor Relations Contact | |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Biotechnology | Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal General Counsel | |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
| Rotman School of Management | College/University | Corporate Officer/Principal | |
| TRUE NORTH COMMERCIAL REAL ESTATE INVESTMENT TRUST | Real Estate Investment Trusts | Director/Board Member | |
SolutionInc Ltd.
 SolutionInc Ltd. Packaged SoftwareTechnology Services Part of SolutionInc Technologies Ltd., SolutionInc Ltd. provides conferencing wifi network solutions for any facility size. SolutionInc is based in Halifax, CA and was acquired by SolutionInc Technologies Ltd. on June 28, 2002 for $15.38 million. The Canadian company's network services help venues attract conferences and meetings by providing a reliable and robust wifi network that exceeds their expectations. The CEO of the company is Glen Lavigne. | Packaged Software | Director of Finance/CFO | |
| Acadia University | College/University | Undergraduate Degree | |
| Dalhousie University | College/University | Doctorate Degree Doctorate Degree | |
| Memorial University of Newfoundland | College/University | Undergraduate Degree Graduate Degree | |
| St. Mary's University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| University of Toronto | College/University | Masters Business Admin | |
| University of Montréal | College/University | Undergraduate Degree | |
| University of Saint Mary | College/University | Masters Business Admin | |
| Wesleyan University | College/University | Undergraduate Degree | |
| L'Université d'Angers | College/University | Graduate Degree | |
| Université Laval | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
| TRICON CAPITAL GROUP | Real Estate Development | Director/Board Member | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Pacrim Hospitality Services, Inc.
 Pacrim Hospitality Services, Inc. Hotels/Resorts/Cruise linesConsumer Services Pacrim Hospitality Services, Inc. operates as a hotel management and development company. It provides management, operational, and consulting services. The company was founded on December 22, 2004 and is headquartered in Calgary, Canada. | Hotels/Resorts/Cruise lines | Director of Finance/CFO | |
| Habitat for Humanity Nova Scotia | Chairman | ||
CTI Life Sciences Fund LP
 CTI Life Sciences Fund LP Investment ManagersFinance CTI Life Sciences Fund LP invests in high quality emerging life sciences companies located in Canada. The fund targets companies operating in the fields of pharmaceuticals and biotechnology companies. It provides financing for seed, early and development stage capital requirements. It also act as lead investor. | Investment Managers | Corporate Officer/Principal | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
Public Health Research Institute Center
 Public Health Research Institute Center Medical/Nursing ServicesHealth Services The Public Health Research Institute Center provides biomedical research. The private company is based in Newark, NJ. | Medical/Nursing Services | Director/Board Member | |
BioTalent Canada
 BioTalent Canada Miscellaneous Commercial ServicesCommercial Services BioTalent Canada is a non-profit organization, which focuses on building partnerships and skills for Canada?s bio-economy to ensure the industry has access to job-ready people. It connects employers with job seekers, delivers human resource information, and skills development tools so the biotech industry through projects, research and product development .The company is headquartered in Ottawa, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Noble Denton Group Ltd.
 Noble Denton Group Ltd. Miscellaneous Commercial ServicesCommercial Services Noble Denton Group Ltd. provides marine & offshore engineering and consultancy services. It provides technical service to the oil and gas industry and help to design, build, install and operate oil and gas onshore, maritime and offshore assets to ensure safety, and sustainability. The company was founded in 1904 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director of Finance/CFO | |
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Xagenic, Inc.
 Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | Medical Specialties | Director/Board Member | |
| NOUVEAU MONDE GRAPHITE INC. | Other Metals/Minerals | Investor Relations Contact | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director of Finance/CFO | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
| Bionova | Director/Board Member | ||
Consortium Québécois sur la Découverte du Médicament
 Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann. | Miscellaneous Commercial Services | Director/Board Member | |
| APPILI THERAPEUTICS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Starlight Group Property Holdings, Inc.
 Starlight Group Property Holdings, Inc. Financial ConglomeratesFinance Starlight Group Property Holdings, Inc. is a Canadian real estate company that specializes in multi-family and single-family properties. The private company is based in Toronto, CA. The company focuses on areas with strong population, economic, and employment rates. The company has institutional partnerships and a leadership team. Starlight has a history timeline and a multi-family home page. The company also has a multi-family (no. 1) value-add fund and a multi-family portfolio. and has subsidiaries in United States and Canada. The CEO of the company is Daniel Drimmer. | Financial Conglomerates | Director of Finance/CFO | |
Rome Therapeutics, Inc.
 Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO | |
| VM HOTEL ACQUISITION CORP. | Financial Conglomerates | Founder | |
| Chartered Professional Accountants of Quebec | Corporate Officer/Principal |
Statistieken
Internationaal
| Canada | 30 |
| Verenigde Staten | 16 |
| Frankrijk | 3 |
| Hongkong | 2 |
| Duitsland | 2 |
Sectoraal
| Consumer Services | 17 |
| Health Technology | 15 |
| Finance | 7 |
| Commercial Services | 6 |
| Utilities | 2 |
Operationeel
| Director/Board Member | 102 |
| Corporate Officer/Principal | 59 |
| Independent Dir/Board Member | 36 |
| Chief Executive Officer | 25 |
| Director of Finance/CFO | 25 |
Sterkste connecties
| Insiders | |
|---|---|
| Wade Dawe | 27 |
| Julia Gregory | 22 |
| Pierre Labbé | 19 |
| Shermaine Tilley | 17 |
| James Hall | 16 |
| Andrew Sheldon | 14 |
| Wayne Pisano | 14 |
| Markus Warmuth | 11 |
| Tracy Sherren | 11 |
| Alfred A. Smithers | 8 |
| Kyle Kuvalanka | 8 |
| Kimberly Stephens | 7 |
| Jennifer Schmitke | 7 |
| Jeremy Graff | 7 |
| Michael P. Bailey | 7 |
- Beurs
- Insiders
- Ryan Marshall
- Bedrijfsconnecties
